Top Markets
Coin of the day
Jenscare Scientific Co., Ltd. Jenscare Scientific Co., Ltd.

Jenscare Scientific Co., Ltd.

9877
株式のランク #15056
Jenscare Scientific Co., Ltd. operates as a medical technology enterprise... Jenscare Scientific Co., Ltd. operates as a medical technology enterprise dedicated to advancing interventional therapies for structural heart conditions within the People's Republic of China. Among its pipeline, the company features LuX-Valve, an investigational transcatheter tricuspid valve replacement (TTVR) system designed for patients suffering from severe tricuspid regurgitation who face elevated surgical risks. Additionally, Ken-Valve represents another key product candidate, a transcatheter aortic valve replacement (TAVR) aimed at addressing severe aortic regurgitation, often co-occurring with aortic stenosis. The applications of Jenscare's portfolio extend to a range of structural cardiac maladies, including disorders of the tricuspid, aortic, and mitral valves, as well as heart failure. Founded in 2011, the company maintains its principal place of business in Ningbo, People's Republic of China.
株価
$0.90187992
時価総額
$376.23M
変化(1日)
-2.69%
変化(1年)
-14.56%
CN
取引 Jenscare Scientific Co., Ltd. (9877)

カテゴリー

Jenscare Scientific Co., Ltd.(9877)のP/B比率
2026 時点のP/B比率 TTM: 0
Jenscare Scientific Co., Ltd. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
Jenscare Scientific Co., Ltd. の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率